Lipocine Inc. (LPCN)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Lipocine Inc. reported revenue of $1.98M, down 82.3% from the prior year. The company ran a net loss, with a net margin of -487.1%. It held $17.01M in total assets against $2.53M in total liabilities.
Key ratios (FY2025)
-524.7%
Operating margin
-487.1%
Net margin
-66.5%
Return on equity
-82.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.98M | $11.20M | -$2.85M | $500.0K | $16.14M | $0 | $165.0K | $428.0K | $0 | $0 |
| Operating Income | -$10.37M | -$1.16M | -$17.93M | -$12.12M | $3.15M | -$18.00M | -$12.90M | -$11.33M | -$21.22M | -$19.19M |
| Net Income | -$9.63M | $8.4K | -$16.35M | -$10.76M | -$634.4K | -$20.96M | -$13.01M | -$11.66M | -$20.98M | -$18.97M |
| EPS (Diluted) | $-1.69 | — | $-3.14 | $-2.15 | $-0.01 | $-0.38 | $-0.50 | $-0.55 | $-1.05 | $-1.04 |
| Total Assets | $17.01M | $22.51M | $23.00M | $37.54M | $52.48M | $25.35M | $19.66M | $20.85M | $25.33M | $27.34M |
| Total Liabilities | $2.53M | $1.51M | $2.63M | $1.91M | $6.91M | $10.01M | $13.37M | $11.42M | $6.35M | $1.33M |
| Shareholders' Equity | $14.48M | $21.00M | $20.37M | $35.63M | $45.57M | $15.34M | $6.29M | $9.43M | $18.98M | $26.02M |
| Cash & Equivalents | $5.21M | $6.21M | $4.77M | $3.15M | $2.95M | $19.22M | $9.73M | $8.08M | $3.21M | $5.56M |
| Operating Cash Flow | -$9.76M | -$1.22M | -$11.87M | -$11.97M | -$4.41M | -$15.30M | -$11.67M | -$12.08M | -$16.70M | -$18.28M |
| Capital Expenditures | — | $90.1K | $13.2K | $133.8K | $7.6K | — | — | $0 | $0 | $59.6K |
| Shares Outstanding | 6.16M | 5.35M | 5.32M | 5.23M | 88.29M | 70.04M | 37.65M | 21.73M | 21.26M | 18.46M |